Caring for a Loved One

As a caregiver it is important to have an understanding of type 2 diabetes and the impact it will have on the person within your care. You can play a meaningful role by encouraging consistency in a loved one's diabetes management program. This includes blood sugar monitoring and taking medication as directed by their doctor, careful management of diet, exercising (as recommended by their doctor), and regular visits with doctors.

Checking blood sugar levels

As a caregiver, you can encourage the person you're caring for to check their blood sugar numbers as directed by their doctor.

Managing diet

Food choices are very important for people with type 2 diabetes. You can help the person in your care choose foods and eat well-balance meals as directed by their healthcare provider.

Encourage exercise

Regular exercise helps control blood sugar levels and is associated with many health benefits. You can help the person in your care understand the importance of physical activity and encourage them to follow the exercise program recommended by their healthcare provider.

Monitoring medication

Most people with diabetes also have other medical conditions. Know the medications the person under your care is taking and understand how each of them works and their potential side effects. Inform the doctor immediately if the person has any reaction to the medications. Ensure that medications are taken or given on time and regularly, as prescribed by the doctor.

Offering support

Diabetes care is more than just taking care of the disease. The person you care for will need support. This may be expressed through encouraging words, insightful ideas, and loving reminders. You may be able to suggest solutions to obstacles and help the affected person discover their own motivation for lifestyle changes.

Onglyza gives you extra help to treat high blood sugar

Get Info

Learn how Onglyza can help you achieve better blood sugar control.

What You Need To Know
As A Caregiver It's Important Io Take Care Of Yourself Too

IMPORTANT INFORMATION ABOUT ONGLYZA™ (saxagliptin)

Approved Uses

ONGLYZA™ (saxagliptin) is a prescription medicine used along with diet and exercise to lower blood sugar in adults with type 2 diabetes mellitus.

ONGLYZA has not been studied with insulin.

ONGLYZA should not be used to treat people with type 1 diabetes or to treat diabetic ketoacidosis (dangerously high levels of certain acids, known as ketones, in the blood or urine).

Important Safety Information

When ONGLYZA is used with certain other diabetes medicines to treat high blood sugar, such as a sulfonylurea, low blood sugar (hypoglycemia) may occur. Symptoms of low blood sugar include shaking, hunger, sweating, headache, rapid heartbeat, change in mood, and change in vision. Follow your healthcare provider's instructions for treating low blood sugar.

If you have allergic (hypersensitivity) reactions, such as rash, hives, and swelling of the face, lips, and throat, stop taking ONGLYZA and call your healthcare provider right away.

When ONGLYZA is used with a thiazolidinedione (TZD), such as pioglitazone or rosiglitazone, to treat high blood sugar, peripheral edema (fluid retention) may become worse. If you have symptoms of peripheral edema, such as swelling of hands, feet, or ankles, call your healthcare provider.

The most common side effects with ONGLYZA include upper respiratory tract infection, urinary tract infection, and headache.

Your healthcare provider should test your blood to measure how well your kidneys work. You may need a lower dose of ONGLYZA if your kidneys are not working well.

Tell your healthcare provider if you start or stop taking other medications, including antibiotics, antifungals or HIV/AIDS medications, as your healthcare provider may need to change your dose of ONGLYZA.

Tell your healthcare provider if you are pregnant or breast-feeding, or plan to become pregnant or breast-feed.

Please see US Full Prescribing Information, including Patient Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Bristol-Myers Squibb and AstraZeneca do not review the information on this Web site and/or database for content, accuracy, or completeness. Use of and access to this information is subject to the terms, limitations, and conditions set by the Web site and/or database producer.

Bristol-Myers Squibb and AstraZeneca make no representation as to the accuracy or any other aspect of the information contained on such Web site and/or database, nor does Bristol-Myers Squibb or AstraZeneca necessarily endorse such Web site and/or database.

Bristol-Myers Squibb and AstraZeneca do not review the information on this Web site and/or database for content, accuracy, or completeness. Use of and access to this information is subject to the terms, limitations, and conditions set by the Web site and/or database producer.

Bristol-Myers Squibb and AstraZeneca make no representation as to the accuracy or any other aspect of the information contained on such Web site and/or database, nor does Bristol-Myers Squibb or AstraZeneca necessarily endorse such Web site and/or database.